---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-021107"
form_type: "8-K"
ticker: "AMRX"
cik: "0001723128"
company_name: "Amneal Pharmaceuticals, Inc."
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T19:13:16.795134+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Amneal shareholders elect all 11 directors, approve say-on-pay at annual meeting

## Summary
- All 11 director nominees elected; votes ranged from 238.7M (Meister) to 254.4M (Yanai) for.
- Advisory vote on NEO compensation approved with 254.4M for, 1.2M against.
- Ratification of Ernst & Young as auditor for FY2024 passed with 279.1M for, 0.6M against.
- Broker non-votes of ~24.1M shares on director election and say-on-pay proposals.

## SEC filing metadata
- accession: 0001628280-24-021107
- form_type: 8-K
- ticker: AMRX
- cik: 0001723128
- company_name: Amneal Pharmaceuticals, Inc.
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1723128/000162828024021107/0001628280-24-021107-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1723128/000162828024021107/amrx-20240502.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-021107
- JSON: https://secwatch.observer/filing/0001628280-24-021107.json
- Plain text: https://secwatch.observer/filing/0001628280-24-021107.txt

## Key facts
- Shareholder Votes
  Amneal Pharmaceuticals, Inc. shareholders approved To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 at the 2024-05-02 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2024-05-02
  source text: Proposal 3 : To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024: For Against Abstain Broker Non-Votes 279,106,284 624,760 38,456 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1723128/000162828024021107/0001628280-24-021107-index.htm
- Shareholder Votes
  Amneal Pharmaceuticals, Inc. shareholders approved Election of director nominees to hold office until the 2025 Annual Meeting of Stockholders at the 2024-05-02 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-05-02
  source text: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successors are elected and qualified: For Against Abstain Broker Non-Votes Emily Peterson Alva 253,927,467 1,736,375 40,449 24,065,209
  evidence_url: https://www.sec.gov/Archives/edgar/data/1723128/000162828024021107/0001628280-24-021107-index.htm
- Shareholder Votes
  Amneal Pharmaceuticals, Inc. shareholders approved To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers at the 2024-05-02 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2024-05-02
  source text: Proposal 2 : To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers: For Against Abstain Broker Non-Votes 254,365,134 1,199,935 139,222 24,065,209
  evidence_url: https://www.sec.gov/Archives/edgar/data/1723128/000162828024021107/0001628280-24-021107-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.